JP2025508798A5 - - Google Patents

Info

Publication number
JP2025508798A5
JP2025508798A5 JP2024549607A JP2024549607A JP2025508798A5 JP 2025508798 A5 JP2025508798 A5 JP 2025508798A5 JP 2024549607 A JP2024549607 A JP 2024549607A JP 2024549607 A JP2024549607 A JP 2024549607A JP 2025508798 A5 JP2025508798 A5 JP 2025508798A5
Authority
JP
Japan
Prior art keywords
peo
polymer
lipid
approximately
blocks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549607A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508798A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/054613 external-priority patent/WO2023161378A1/en
Publication of JP2025508798A publication Critical patent/JP2025508798A/ja
Publication of JP2025508798A5 publication Critical patent/JP2025508798A5/ja
Pending legal-status Critical Current

Links

JP2024549607A 2022-02-23 2023-02-23 脂質とブロックコポリマーとを含むポリマー-脂質ハイブリッドナノ粒子ならびにその作製方法および使用方法 Pending JP2025508798A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158324.8 2022-02-23
EP22158324 2022-02-23
PCT/EP2023/054613 WO2023161378A1 (en) 2022-02-23 2023-02-23 Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof

Publications (2)

Publication Number Publication Date
JP2025508798A JP2025508798A (ja) 2025-04-10
JP2025508798A5 true JP2025508798A5 (cg-RX-API-DMAC10.html) 2026-03-02

Family

ID=80448440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549607A Pending JP2025508798A (ja) 2022-02-23 2023-02-23 脂質とブロックコポリマーとを含むポリマー-脂質ハイブリッドナノ粒子ならびにその作製方法および使用方法

Country Status (6)

Country Link
US (1) US20250235532A1 (cg-RX-API-DMAC10.html)
EP (1) EP4482477A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025508798A (cg-RX-API-DMAC10.html)
AU (1) AU2023226175A1 (cg-RX-API-DMAC10.html)
CA (1) CA3244864A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023161378A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026062291A1 (en) 2024-09-23 2026-03-26 Aldexchem Kft. Silicon-containing spleen-targeted lnp delivery systems
WO2026129142A1 (zh) * 2024-12-17 2026-06-25 西湖实验室(生命科学和生物医学浙江省实验室) 新型脂质纳米颗粒系统、car-t构建方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
CA3170184A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
US10501512B2 (en) * 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
CN111450060A (zh) 2012-11-19 2020-07-28 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
US20150366997A1 (en) * 2012-12-07 2015-12-24 Shire Human Genetics Therapies, Inc. COMPOSITIONS AND METHODS FOR mRNA DELIVERY
JP2017520549A (ja) * 2014-06-26 2017-07-27 ラモット アット テル アビブ ユニバーシティ, リミテッド 核酸の送達のためのリポソーム製剤
WO2016154432A1 (en) 2015-03-24 2016-09-29 VaxLiant, LLC Adjuvant compositions and related methods
CN116322788A (zh) * 2020-05-19 2023-06-23 奥纳治疗公司 环状rna组合物和方法

Similar Documents

Publication Publication Date Title
Rinoldi et al. Nanotechnology‐assisted RNA delivery: from nucleic acid therapeutics to COVID‐19 vaccines
Zhang et al. DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine
Mahmoodi Chalbatani et al. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
Tan et al. Optimization of an mRNA vaccine assisted with cyclodextrin-polyethyleneimine conjugates
EP3573656B1 (en) Core/shell structure platform for immunotherapy
Ruan et al. Advanced biomaterials for cell‐specific modulation and restore of cancer immunotherapy
JP6782415B2 (ja) 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法
CN114746401A (zh) 用于核酸递送的可离子化脂质
Krishnamachari et al. Nanoparticle delivery systems in cancer vaccines
CN116685331A (zh) 用融合相关的小跨膜蛋白配制的蛋白脂质囊泡
KR102948789B1 (ko) 항원 제시 세포를 표적으로 하는 지질 조성물 및 이의 용도
Huang et al. Recent advances in delivery systems for genetic and other novel vaccines
CN119654141A (zh) 脂质纳米颗粒的组合物
Gu et al. Building a better silver bullet: current status and perspectives of non‐viral vectors for mRNA vaccines
WO2025113407A1 (zh) 高效递送疫苗的脂质体载体及脂质体疫苗的制备与用途
CN110448695A (zh) 一种mRNA疫苗递送载体及其制备方法
CN119930462B (zh) 基于RLRs受体激动剂的疫苗佐剂脂质化合物、包含其的组合物及用途
US20260102477A1 (en) Tumor-Associated Antigen Based Cancer Vaccine
Liu et al. Antigen-encoding circular single-stranded DNA for cancer vaccine
Dodopoulos et al. Delivering mRNA vaccines: Emerging strategies and clinical potential of nanocarrier systems for cancer treatment
Yasar Non-invasive vaccination by nanoparticle-based messenger RNA (mRNA) delivery via the transfollicular route
HK40106866B (en) Lipid composition of targeted antigen presenting cell and application thereof
HK40106866A (en) Lipid composition of targeted antigen presenting cell and application thereof
WO2024216243A2 (en) Peptide-based vaccines and methods for treatment
HK40121626A (en) Toll-like receptor agonist-based vaccine adjuvant lipid compound and use thereof